Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I. (Q39934395)

From Wikidata
Jump to navigation Jump to search
scientific article published on 28 October 2009
edit
Language Label Description Also known as
English
Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I.
scientific article published on 28 October 2009

    Statements

    Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I. (English)
    Joel W Hay
    Jim Smeeding
    Norman V Carroll
    Michael Drummond
    Edward C Mansley
    C Daniel Mullins
    Jack M Mycka
    Brian Seal
    Lizheng Shi
    28 October 2009

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit